CCTC Living Donor Assessment Process 3

Question 1

During cardiovascular risk assessment for a living donor, which finding would typically prompt exclusion from donation?

Accepted Answer

Recent myocardial infarction within the past 6 months

Answer

A recent MI indicates significant cardiovascular instability that poses unacceptable surgical and anesthetic risk for a living donor.

Question 2

What does ABO compatibility testing determine in the living donor evaluation?

Accepted Answer

Whether the donor's blood type is compatible for organ transplantation

Answer

ABO compatibility testing confirms that donor and recipient blood types are compatible to prevent hyperacute rejection.

Question 3

Which urinalysis finding in a living kidney donor candidate would most warrant further nephrological workup?

Accepted Answer

Persistent microalbuminuria on two or more occasions

Answer

Persistent microalbuminuria suggests subclinical kidney disease and requires nephrology evaluation before clearing a candidate for donation.

Question 4

A living donor candidate is found to have a solitary kidney on imaging despite having two normal kidneys on prior records. What is the most appropriate action?

Accepted Answer

Repeat the imaging to rule out technical error before making any decision

Answer

Before any clinical decision, the imaging finding should be confirmed with repeat or alternate imaging to rule out technical artifact.

Question 5

When does the UNOS Living Donor Follow-Up policy require transplant centers to collect and submit follow-up data on living donors?

Accepted Answer

At 6 months, 1 year, and 2 years post-donation

Answer

UNOS/OPTN policy mandates follow-up data collection at 6 months, 1 year, and 2 years post-donation to monitor donor outcomes.

CCTC - Certified Clinical Transplant Coordinator Practice Test

CCTC - Certified Clinical Transplant Coordinator Practice Test

CCTC Living Donor Assessment Process 3